Bimodal intensity-modulated radiotherapy in combination with carbon ion therapy (C12) of mucosal melanomas - data of the last decade from Heidelberg University Hospital
The combination of IMRT with carbon ion therapy in the treatment of mucosal melanoma provides promising local control rates with mild acute toxicity despite unfavorable patient preselection. The unfavorable overall survival as well as progression-free survival rates indicate that concomitant systemic therapies should be the subject of future research.
Authors
- Semi Harrabi (ORCID: https://orcid.org/0000-0003-1195-7150)
- Maximilian Deng (ORCID: https://orcid.org/0000-0003-4925-7600)
- Sebastian Regnery (ORCID: https://orcid.org/0000-0002-6820-884X)
- Kristin Lang (ORCID: https://orcid.org/0000-0002-5355-3173)
- Thomas Mielke
- Katharina Seidensaal (ORCID: https://orcid.org/0000-0001-5969-6426)
- Thomas Held (ORCID: https://orcid.org/0000-0002-3913-4693)
- Lukas Bauer (ORCID: https://orcid.org/0009-0000-7711-934X)
- M. Ellerbrock (ORCID: https://orcid.org/0000-0002-4086-0908)
- Jessica Cecile Hassel (ORCID: https://orcid.org/0000-0001-7575-6230)
- Klaus K Herfarth (ORCID: https://orcid.org/0000-0002-6325-4193)
- Jürgen Debus
- Angela Paul
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Heidelberger Institut für Radioonkologie (DE)
- National Center for Tumor Diseases (DE)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-11-22
- DOI
- https://doi.org/10.3389/fonc.2024.1437412
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.00